UniCamillus meets leading international experts in cancer immunotherapy

French scientists Guido Kroemer and Laurence Zitvogel, world experts in the field of antineoplastic treatments, visited UniCamillus

On Friday 3rd November, UniCamillus was pleased to welcome two international luminaries in the field of immuno-oncology research: UniCamillus Rector Gianni Profita met with Professor Guido Kroemer and Professor Laurence Zitvogel, both from the Gustave Roussy Cancer Campus in Paris.

Professor Kroemer is one of the world’s most cited scientists and has made important discoveries in the field of molecular biology, contributing to the understanding of cellular mechanisms such as apoptosis and autophagy. In addition, his research has helped to define the mechanisms that identify immunogenic cell death in the context of potential antineoplastic treatments.

Professor Zitvogel has pioneered the concept of immunogenic cell death, that is death of cancer cells that activates an immune response against the tumour itself. Her research in immuno-oncology has laid the groundwork for major advances in the understanding of tumour immunology.

The studies of world experts in tumour immunotherapy have led to remarkable discoveries, paving the way for equally remarkable therapeutic innovations.

Historical collaborators of the two scientists also attended the meeting: Professor Giuseppe Ippolito and Professor Roberta Nardacci from UniCamillus, Professor Mauro Piacentini from the University of Rome Tor Vergata, and UniCamillus Research Delegate Professor Emiliano Maiani.

“I am very pleased and honoured to have had the opportunity to meet Professor Guido Kroemer and Professor Laurence Zitvogel“, said Rector Profita satisfactorily. “This meeting marked an important step forward in the collaboration between UniCamillus and the Gustave Roussy Cancer Campus, opening the doors to future advances in our understanding of immuno-oncology therapy. We look forward to working together to achieve ever more ambitious goals in our commitment to fight cancer”.